EC5026   Click here for help

GtoPdb Ligand ID: 12750

Synonyms: BPN-19186 | BPN19186 | EC-5026
Compound class: Synthetic organic
Comment: EC5026 is a first-in-class, orally active soluble epoxide hydrolase (sEH; epoxide hydrolase 2; EPHX2) inhibitor [1]. It was designed fo treat inflammatory and neuropathic pain.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 70.67
Molecular weight 405.39
XLogP 2.94
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC[C@H](C)C(=O)N1CCC(CC1)NC(=O)NC2=CC=C(C(=C2)F)OC(F)(F)F
Isomeric SMILES O=C(NC1=CC(F)=C(C=C1)OC(F)(F)F)NC2CCN(C([C@H](CC)C)=O)CC2
InChI InChI=1S/C18H23F4N3O3/c1-3-11(2)16(26)25-8-6-12(7-9-25)23-17(27)24-13-4-5-15(14(19)10-13)28-18(20,21)22/h4-5,10-12H,3,6-9H2,1-2H3,(H2,23,24,27)/t11-/m0/s1
InChI Key LHRXHTKENPCGSZ-NSHDSACASA-N
No information available.
Summary of Clinical Use Click here for help
EC5026 was advanced to clinical studies.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04228302 Safety, Tolerability, and Pharmacokinetics of Oral EC5026 in Healthy Subjects Phase 1 Interventional EicOsis Human Health Inc.